These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 14708972)
1. The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase. Pollard PJ; Wortham NC; Tomlinson IP Ann Med; 2003; 35(8):632-9. PubMed ID: 14708972 [TBL] [Abstract][Full Text] [Related]
2. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Pollard PJ; Brière JJ; Alam NA; Barwell J; Barclay E; Wortham NC; Hunt T; Mitchell M; Olpin S; Moat SJ; Hargreaves IP; Heales SJ; Chung YL; Griffiths JR; Dalgleish A; McGrath JA; Gleeson MJ; Hodgson SV; Poulsom R; Rustin P; Tomlinson IP Hum Mol Genet; 2005 Aug; 14(15):2231-9. PubMed ID: 15987702 [TBL] [Abstract][Full Text] [Related]
3. Isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH), fumarate hydratase (FH): three players for one phenotype in cancer? Laurenti G; Tennant DA Biochem Soc Trans; 2016 Aug; 44(4):1111-6. PubMed ID: 27528759 [TBL] [Abstract][Full Text] [Related]
4. Increased HIF1 alpha in SDH and FH deficient tumors does not cause microsatellite instability. Lehtonen HJ; Mäkinen MJ; Kiuru M; Laiho P; Herva R; van Minderhout I; Hogendoorn PC; Cornelisse C; Devilee P; Launonen V; Aaltonen LA Int J Cancer; 2007 Sep; 121(6):1386-9. PubMed ID: 17520677 [TBL] [Abstract][Full Text] [Related]
5. Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors. Hoekstra AS; de Graaff MA; Briaire-de Bruijn IH; Ras C; Seifar RM; van Minderhout I; Cornelisse CJ; Hogendoorn PC; Breuning MH; Suijker J; Korpershoek E; Kunst HP; Frizzell N; Devilee P; Bayley JP; Bovée JV Oncotarget; 2015 Nov; 6(36):38777-88. PubMed ID: 26472283 [TBL] [Abstract][Full Text] [Related]
7. The role of metabolic enzymes in mesenchymal tumors and tumor syndromes: genetics, pathology, and molecular mechanisms. Schaefer IM; Hornick JL; Bovée JVMG Lab Invest; 2018 Apr; 98(4):414-426. PubMed ID: 29339836 [TBL] [Abstract][Full Text] [Related]
8. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. King A; Selak MA; Gottlieb E Oncogene; 2006 Aug; 25(34):4675-82. PubMed ID: 16892081 [TBL] [Abstract][Full Text] [Related]
9. A role for mitochondrial enzymes in inherited neoplasia and beyond. Eng C; Kiuru M; Fernandez MJ; Aaltonen LA Nat Rev Cancer; 2003 Mar; 3(3):193-202. PubMed ID: 12612654 [TBL] [Abstract][Full Text] [Related]
10. Mitochondrial dysfunctions in cancer: genetic defects and oncogenic signaling impinging on TCA cycle activity. Desideri E; Vegliante R; Ciriolo MR Cancer Lett; 2015 Jan; 356(2 Pt A):217-23. PubMed ID: 24614286 [TBL] [Abstract][Full Text] [Related]
11. A review of the tumour spectrum of germline succinate dehydrogenase gene mutations: Beyond phaeochromocytoma and paraganglioma. MacFarlane J; Seong KC; Bisambar C; Madhu B; Allinson K; Marker A; Warren A; Park SM; Giger O; Challis BG; Maher ER; Casey RT Clin Endocrinol (Oxf); 2020 Nov; 93(5):528-538. PubMed ID: 32686200 [TBL] [Abstract][Full Text] [Related]
14. Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas. Castro-Vega LJ; Buffet A; De Cubas AA; Cascón A; Menara M; Khalifa E; Amar L; Azriel S; Bourdeau I; Chabre O; Currás-Freixes M; Franco-Vidal V; Guillaud-Bataille M; Simian C; Morin A; Letón R; Gómez-Graña A; Pollard PJ; Rustin P; Robledo M; Favier J; Gimenez-Roqueplo AP Hum Mol Genet; 2014 May; 23(9):2440-6. PubMed ID: 24334767 [TBL] [Abstract][Full Text] [Related]
15. On the association of succinate dehydrogenase mutations with hereditary paraganglioma. Baysal BE Trends Endocrinol Metab; 2003 Dec; 14(10):453-9. PubMed ID: 14643060 [TBL] [Abstract][Full Text] [Related]
16. The functional roles of TCA cycle metabolites in cancer. Eniafe J; Jiang S Oncogene; 2021 May; 40(19):3351-3363. PubMed ID: 33864000 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Xiao M; Yang H; Xu W; Ma S; Lin H; Zhu H; Liu L; Liu Y; Yang C; Xu Y; Zhao S; Ye D; Xiong Y; Guan KL Genes Dev; 2012 Jun; 26(12):1326-38. PubMed ID: 22677546 [TBL] [Abstract][Full Text] [Related]
18. Differential metabolic consequences of fumarate hydratase and respiratory chain defects. Raimundo N; Ahtinen J; Fumić K; Barić I; Remes AM; Renkonen R; Lapatto R; Suomalainen A Biochim Biophys Acta; 2008 May; 1782(5):287-94. PubMed ID: 18313410 [TBL] [Abstract][Full Text] [Related]
19. Toward an improved definition of the genetic and tumor spectrum associated with SDH germ-line mutations. Evenepoel L; Papathomas TG; Krol N; Korpershoek E; de Krijger RR; Persu A; Dinjens WN Genet Med; 2015 Aug; 17(8):610-20. PubMed ID: 25394176 [TBL] [Abstract][Full Text] [Related]
20. Knowledge-Based Therapeutics for Tricarboxylic Acid (TCA) Cycle-Deficient Cancers. Peled D; Casey R; Gottlieb E Cold Spring Harb Perspect Med; 2024 Sep; 14(9):. PubMed ID: 38503501 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]